Together, the restored insulin-stimulated FLNA—IRβ dissociation and the restored responsiveness of mTOR to insulin show a coordinated improvement in insulin sensitivity in AD patient lymphocytes following simufilam. This evidence concerns the gene MTOR and Alzheimer disease.